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Abstract: New dosage forms able to control drug release in the gastro-intestinal media have been prepared and 
investigated in this paper. Two different type of medicinal agent bonding (MA), in our case Benzocaine (Bz), 
were chosen in order to examine drug release.  
i)  MA attached to ethylenic monomer (m,p-vinylbenzaldehyde), condensation reaction.  
ii)  The copolymer carrier (Cp) is obtained by copolymerizing this monomer. 
These two carriers were well characterized by microanalysis, FTIR, DSC (Tg) and GPC (Ip) and the two 
fraction α and β were calculated from elemental analyses of Cp. The results showed good polydispersity and 
low  average  molecular  weight.  MA  linked  to  an  organic  product  by  the  azomethine  function  (C=N), 
hydrolytically sensitive, allowed controlled release of Bz, from the monomer carrier and from the bending 
Schiff bases groups. Theoretical and experimental analyses of controlled release of Bz kinetics from monomer 
and copolymer carriers were conducted for the case of contact with synthetic gastro-intestinal fluids at various 
pH (1,2; 6,0 and 8,0) at 37°C.  
The  process  was  found  to  be  controlled  by  the  nature  of  media  (heterogeneous),  which  involved  the 
preliminary hydrolysis, and the drug (Bz) diffusing out of structure of copolymer (Cp) to the external aqueous 
media.  
The results obtained on the rate of delivery showed a clear difference between pH = 1,2 and pH = 6,0 and 8,0 
based on:  
i)  The cation of p-aminoniumbenzoic acid (PABAH
+) release at pH = 1,2  
ii)  Bz release at pH = 6,0 and 8,0  
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Introduction   
 
Systemic treatment is often administered via the gastrointestinal tract, since many dosage 
forms are easy to swallow. For classical dosage forms the drug release generally follows the 
first-order reaction kinetics. The drug is liberated very rapidly from the form, and as a result 
the drug concentration in the gastrointestinal liquid and in the blood builds up to a maximum 
concentration and then falls exponentially until the next dose.  
An  undulating  concentration  figure  of  the  drug  is  obtained,  high  concentrations 
alternating  with  low  concentrations.  In  order  to  facilitate  the  treatment  by  reducing  the 
number of taken doses, the active substance has to be formulated in such a way that its Mediterr.J.Chem., 2014, 3(2),  H. Merine et al.  854 
 
 
release is delayed and controlled. Moreover, the development of new systems able to release 
a controlled amount of drug over a defined period  of time represents  also an important 
pathway of drug effects optimization. These therapeutic systems offer important advantages 
over traditional dosage forms in diseases requiring the most constant possible blood levels 
over  prolonged  therapeutic  duration:  uniform  blood  levels  are  achieved,  smaller  total 
amounts of drug are needed, side effects are reduced and the therapy is optimized
1.  
Many  devices  able  to  control  the  drug  release  have  been  prepared  in  various  ways, 
following 3 mechanisms, namely: osmosis, polymer erosion and diffusion, the release being 
often controlled by more than one mechanism
2. Another interesting way is to attach the drug 
to the polymer by means of a labile chemical bond.   
As our paper is concerned with the last process i.e, attaching the drug to a biocompatible 
polymer, it is interesting to examine the results which have been obtained previously in the 
literature.  
Various  drugs  have  been  attached  to  low  molecular-weight  polyethylene  glycol: 
procaine
3, atropine
4, esters of salicylic acid
5, penicillin, aspirin, quinidine and atropine
6.  
The organic function chosen for the polymer-drug bonding is very often, ester or carbonate 
and, sometimes acetal, because their hydrolysis in acidic or basic media are well-known in 
organic chemistry.  
Another process applied more recently, is synthesizing monomer with pendant drug, and 
then polymerization of the obtained molecule
7-11. Amines such as 5-amino-salicylic acid
12, 
3-aminopyridine
10,11 para-amino benzoic acid
9, para-anisidine
13 and 2-aminothiazole
14 have 
been grafted on styrenic supports. The acrylic and methacrylic supports have been widely 
used for amine drugs  such as  theophylline
15, sulfanilamide
8,  benzoic  acid
16 and anilines 
model
17. In these cases, the released drug depends on the hydrolysis of the function group of 
linkage. 
In this context, we have chosen the Benzocaine (Bz) as anesthetic medical agent, grafted 
via azomethine bond on vinylbenzaldehyd to obtain the monomer carrier Im, which has been 
copolymerized with N-2-vinylpyrrolidone by a radical copolymerization.  
Benzocaine (ethyl4-aminobenzoate), an ester with a long acting local anesthetic, has been 
used for the relief of local pain, among other disorders, as in buccal affections. It also acts 
on the synapses blocking the potential action
18.  
The kinetics of (Bz), released from Im and Cp, have been measured by using a double-
beam UV spectrophotometer in different synthetic liquid at various pH (1,2; 6,0 and 8,0) and 
under the same conditions of temperature (37°C) and stirring (500 rpm).The results showed 
the  cumulative  percentages  of  drug  released  as  function  of  the  hydrolysis  reaction  of 
azomethine bond in first, and, the diffusion of MA from the structure of the carriers in 
second.   
 
Results and Discussion  
Synthesis and characterization 
Synthesis of monomer Im : N-((m,p)- vinylbenzylidène)-benzocaine  
(m,p)vinylbenzaldehyd  VBA  was  synthesized  previously  following  the  Sommelet’s 
method
19, as shown in scheme 1. 
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                              CMS                                                                  VBA         
Scheme1 
 
The  characteristics  of  VBA  are  as  follows,  they  are  in  good  agreement  than  those 
reported in reference
13:  
The principal IR bands are (cm
-1): 1705 (C=O), 2731 and 2825 (C-H aldehyde), 1605 (C=C 
aromatic) and 918 and 989 (C-H vinylic).  
The monomer Im has been synthesized by using the general method described in the 
literature
7,9,20-24.  The scheme 2 shows the synthesis reaction of the monomer support of 
benzocaine. 
 
   VBA                         Bz                          Im 
Scheme2 
 
Characteristics of Im:  
-  Solid aspect, yellow powder, already described
14 
-  Yield: 80% 
-  FTIR spectrum (Figure 1)  (cm-
1): 1655 (C=N), 1707 (C=O, ester), 1450 and 1600 (C=C 
aromatic,  stretching),  900-990  (C-H,  vinylic),  1456  (-CH3,  bending),  2987  (-CH  alkane, 
stretch). 
 
 
Figure 1: FTIR spectrum of Im Mediterr.J.Chem., 2014, 3(2),  H. Merine et al.  856 
 
 
Synthesis  of  copolymer:  poly[N-(m,p)-vinylbenzylidène-benzocaine-co-N-2-
vinylpyrrolidone], Cp 
The  Cp  was  obtained  by  mixing  96%  VP  with  4%  Im,  dissolved  in  anhydrous 
tetrahydrofuran (THF) with 5% (W/W) of azobisisobutyronitrile (AIBN) as initiator, and 
placed in a glass tube (Scheme 3).  
 
Im                      VP                                                         ---[f1]α---[f2]β--- 
                                                                                Cp 
Scheme3 
 
The Cp characteristics are:  
-  Tg = 81±0,1°C (DSC) (glass transition temperature) 
-  n M

  = 10500,  w M

 = 12800,   Ip = 1.21  
-  Copolymerization rate: 84% 
-  Elemental analyses: %N : 10,84% 
(This value enabled us to calculate f1 (89,3%) and f2 (10,7%), the Cp’s molar fractions  
-  IR spectrum (Cp) ( (cm-
1): (Figure 2) 
1670  (C=O*,  VP),  1288,4  (C=C,  aromatic),1423,4  and  1461,9  (C-O**,  VP),                  
2889,2 and 2954,7 (-C-H, alkane, stretching), 1462 (-CH3, bending), 1604,7 (C=C, aromatic, 
stretching). 
*: imine band is masked by the C=O band of VP. 
**:C =O Band of ester is masked by that of the VP. 
We noted a vinylic band absence (out of plane bending) at 900-990cm
-1.  
 
Figure 2: Cp FTIR spectrum  Mediterr.J.Chem., 2014, 3(2),  H. Merine et al.  857 
 
 
Release study 
The  test  “in  vitro”  experiments  conditions  are  carried  out  in  a  closed  flask  with  a 
controlled stirring  rate  (500rpm).  Im  and Cp are insoluble in  synthetic intestinal  gastric 
liquids (100mL).Im and Cp in powder form are dispersed in pure form. Samples (1mL) of 
liquid  were  taken  at  intervals  for  analysis,  after  appropriate  dilutions,  using  UV-Vis-
2401PC-SHIMADZU spectrophotometer calibrated at max of Bz in studied pH. Figure 3 
shows examples of UV absorption spectrum at different concentrations of Bz at pH=8.0.  
 
 
Figure 3: UV benzocaine spectra at pH =8,0 with different concentrations                            
(10
-4; 8x10
-5; 6x10
-5; 4x10
-5; 2x10
-5; 1x10
-5(mol/L) ). 
 
The max and max values are given in table 1: 
 
Table 1:max and max in pH = 1,2; 6 and 8. 
  Bz 
pH=1,2  pH=6,0  pH=8,0 
max (nm)  226  285  285 
max l.mole
-1.cm
-1  13324  17190  16825 
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The Table 2 reports the percentage of the initial mass of drug grafted on Im and Cp and 
percentage of the initial mass of Bz in Im and Cp: copolymer indexed as follow: 
 (-VP)α-(Im-)β Cp 
  % Im/Cp  % Bz/Im  mtotal to release (mg) 
Im  /  58,42  58,42 
Cp  23,15  58,42  13,52 
  -(VP)- : vinylpyrrolidone: as comonomer 
  -(Im)- : monomer Im. 
  %Im/Cp:  fraction of Im in Cp 
  %Bz/Im : percentage of drug in Im 
  mt: total mass to release (mg) 
 
When the monomer and Cp carriers (Im, Cp), in powder form, were soaked in simulated 
intestinalgastric liquids (pH = 1,2; 6 and 8), liberation of the drug was observed with typical 
kinetics as shown in fig. 4 and 5.  
 
Figure 4: Percent released drug as function of time for Im at pH = 1,2; 6,0 and 8,0; T 37°C 
and  500 rpm. 
 
           Figure 5: Percent released drug as function of time for Cp at pH = 1,2; 6,0 and 8,0; T 
37°C and  500 rpm. Mediterr.J.Chem., 2014, 3(2),  H. Merine et al.  859 
 
 
To construe the results of the Bz released, it is necessary to consider: 
•PABAH
+:cation of  p-aminobenzoic acid    
•The hydrophilic patterns (VP) 
• The pK of benzocaine (Bz) (pK = 2,49)
25 and p-aminobenzoic acid(PABA) (pK = 4,9)
26 and 
there solubility.  
It  is  clear  that  we  have  two  different  primary  particles  that  are  released  during  the 
hydrolysis of (Im) and (Cp). 
 
1.  At pH = 1,2 the majority of cation p-ammoniumbenzoic acid (PABAH
+)  is released 
after hydrolysis of the imine function (Im) or groups "pendant" Schiff base of the copolymer 
(Cp)  on one hand and the ester hydrolysis of the  active ingredient (Bz) on the other hand.  
2.  At pH=6.0 and pH= 8,0 we have a benzocaine release; the ester function is not affected 
by hydrolysis at pH above 
 
The results showed that the drug release from monomer in various experimental liquids 
at pH 6,0 and 8,0, is very slow than from the copolymer Cp (figure 6). As a matter of fact, 
the monomer is insoluble in this release medium, and by the prevention of the drug release 
by steric effect of the benzocaine (bulky molecule). The inhibiting action aiming at reach the 
delay  effect  is  compromised  for  copolymer  at  low  molecular  weight  and  based  of                      
N-vinyl-2-pyrrolidone hydrophilic co-monomer.  
 
Figure 6: Percentage of benzocaine released from the copolymer Cp and Im at pH =8.0. 
 
The  release  of  cation  p-ammoniumbenzoic  acid  (PABAH
+),  produced  from  the 
hydrolysis of the ester function unstable with pH = 1,2, presents a release percentage a little 
higher than other pH
9. Also, in acidic pH media, the high percentages of released drug are 
obtained because the hydrolysis of Schiff bases is rapid, reaches 60 % after two hours from 
Im and 50 % for Cp. 
After  study,  it  proved  that  this  kinetics  cannot  be  expressed  or  described  by  simple 
classical  equations.  The  delivery  diffusional  appearance  has  been  proved  when  the 
percentage of drug released has been plotted as function of a square root of time. In fact, a 
linear relationship is observed for short times (figure 7). 
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     Figure 7: Benzocaine rate released from the Cp as function of the square root of time   at 
pH = 1.2, 6.0 and 8.0 
 
Nevertheless, the establishment of the Cranck mathematical model
27 able to describe the 
diffusion model according to the Fick’s laws. The amounts of diffusing substance at time t 
Mt compared to the amount of diffusing substance at infinite time (equilibrium)  M∞ are 
determined by the following relation:   
 
 
        (A) 
 
where R is the macromolecule grains radius.  
The different values of M∞ obtained from the graph of log(Mt/Mi) =f(t), are given in Table 
3.  
 
Table3: The amounts of benzocaîne delivery from a monomer and copolymer                               
at infinite time in the various release media at the different pH. 
pH 
 
1,2  6,0  8,0 
M (Bz) mg  Im  41  5,0  3,11 
Cp  7,275  4,849  4,483 
 
However,  it  is  very  difficult  or  practically  impossible  to  calculate  the  diffusivities 
because we don’t know the dimensions of the grains of Im and Cp. 
 
Conclusion 
 
This paper has paved the way to new oral galenic forms able to control the drug release 
in stomach. In this case, a pharmacologically active monomer or copolymer are prepared 
and soaked at pH = 1,2; 6,0 and 8,0.  The  drug release process of is very complicated 
because  various  matter  transfers  take  place  through  the  structure  of  Cp.  No  analytical 
solution can be found for this problem, numerical methods with finite differences have to be 
built in order to describe the whole process. When the copolymer carrier is in contact with 
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synthetic intestinalgastric, it becomes in gel form, because of the liquid transfer into the 
copolymer. On the other hand, a drug release is observed, which does not follow a classical 
kinetic  equation,  as  the  kinetics  are  partially  controlled  by  diffusion.  Several  factors 
influence the drug release: the nature of the carriers, the rate of hydrolysis of imine function, 
the pH of the medium, and the molecular weight of the polymer support. 
In  order  to  carry  out  this  reaction,  benzocaine  has  been  condensed  with                           
(m,p)-vinylbenzaldehyd  to  give  a  monomer  carrier.  This  monomer  carrier  was 
copolymerized with N-vinyl-2-pyrrolidone. The heterogeneous drug release kinetics have 
been established for 3 different pH, and the results proved that benzocaine release is strongly 
affected by the pH media and, therefore the rate of hydrolysis of Schiff base. 
The study shows that any process of diffusion through these insoluble structures must 
follow four main steps: 
1- The setting in balance of the grains of the supports in the media with the formation of the 
water film around the grain    
2-  The liquid diffusion in the grain structure  
3-  Hydrolysis of the imine  function of the monomer and its copolymer  
4-  Diffusion of the drug out of the supports  
Finally, it is worth to mention that the work does not stop at this step. In this work, we 
also examined the inclusion of the obtained formulations i.e. monomer and copolymer in 
other  polymeric  supports  using  other  techniques  principally  microencapsulation.  The 
purpose is to get a large domain of release drug modification. 
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Experimental Section 
 
Materials and equipments 
(VBA) (m,p) has been synthesized following the Sommelet’s method from a mixture of 
(meta/para)-chloromethylstyrene:  (60/40).  Benzocaine  98  %  of  purity  from  Sigma,                     
N-vinylpyrrolidone from Aldrich, analytical solvents (benzene, tetrahydrofuran, petrol ether, 
and absolute ethanol) used as received. The release media are composed of: HCl and NaCl 
for pH=1.2, KH2PO4 and NaOH for pH=6.0, HCl and Borax for pH=8.0, in accordance with 
US pharmacopeia [28]. 
The average molecular weights Mn and Mw of the copolymer Cp have been obtained by 
KNAUER  apparatus,  equipped  with  a  set  of  columns  Ultra-Styragel  10
-4and  10
-5  A° 
WATERS,  using  polystyrene  as  standards  and  tetrahydrofuran  as  solvent  at  a  flow  of 
0.7mL/mn. The transition temperature of a copolymer has been measured by differential 
scanning calorimetry DSC 92 SETARAM apparatus. IR spectra have been recorded on dried 
KBr disks using SCHIMADZU FTIR-8300 apparatus. Microanalysis of copolymer has been 
established in the Central Analysis Service of CNRS Solaize (France).The UV–Vis spectra 
have been carried by UV-Vis-2401 PCSHIMADZU with double beams controlled by data 
processing, with thermostated cells.  Mediterr.J.Chem., 2014, 3(2),  H. Merine et al.  862 
 
 
Synthesis of monomer and copolymer 
Preparation of (m,p)-Vinylbenzaldehyd (VBA)  
VBA  has  been  prepared  from  a  commercial  mixture  of  meta/para:  60/40 
chloromethylstyrene (CMS), according to SOMMELET method [13]. 0,4mol (56,07g) of 
hexamethylenetetramine (HMTA) has been added to 0,4 mol (60,8g) of fresh distilled CMS 
which has been placed in a flask equipped with refrigerant, and then 125 mL of acetic acid 
has  been  introduced  and  diluted  with125  mL  of  water.  After  adding  some  spangles  of                  
4-tertiobutylcathecol, the mixture has been heated until reflux at 100°C during 2 hours under 
agitation. 100 mL of HCl has been added to the mixture and heated for 15 min. The organic 
phase is extracted with ether oxide and washed several times with Na2CO3 solution at 10 
%and with pure water until neutrality. This phase was dried with Na2SO4 and concentrated 
by rotavapor. The obtained green oil of VBA has been distilled under vacuum (p = 1mmHg) 
and at65 °C of temperature. 
 
Preparation of N-(m,p)-Vinylbenzylidene)-benzocaine 
A  dry  500mL  2-necked  flask  equipped  with  a  magnetic  stirrer  and  a  Dean-Stark 
surmounted by a condenser, has been used for this synthesis. 77mmol of benzocaine were 
dissolved  in  150mL  of  benzene  in  the  presence  of  2mg  of  2,6-di-t-butyl  catechol 
(antioxidant)  and  some  traces  of  para  toluenesulfonic  acid  (PTSA)  as  catalyst  has  been 
reacted under reﬂux. The mixture has been heated until boiling. After cooling, 77mmol of 
(m,p) vinylbenzaldehyd in 50mL of benzene has been added to the initial solution. The 
mixture has been heated until reflux at the azeotrope temperature (experimental T = 79,5 °C) 
in order to eliminate the produced water. After evaporation of the solvent, the residue has 
been recrystallized several times in absolute ethanol.  
 
Preparation of poly[N-(m,p)-vinylbenzylidène-benzocaine -co-N-2-vinylpyrrolidone] 
The obtained monomer (Im) has been copolymerized with N-2-vinylpyrrolidone (VP)at a 
ratio 4/96 of Im/VP, using 2,2-azo-bis-(isobutyronitrile) (AIBN, 5% on mass) as initiator 
and under nitrogen atmosphere, in tetrahydrofuran (THF) solution , at 65°C during 18 hours. 
The obtained copolymer has been purified by re-crystallization in THF/Petrol ether couple. 
Finally, the yellow powder of copolymer has been collected with 84 % of yield. 
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